Certified Dementia Practitioner Amy Schenk joins Suzanne from Cape Coral, Florida, courtesy of Athira Pharma to talk about the impacts of the pandemic on families and people with Alzheimer’s disease. Amy also educates in both Assisted Living and Long Term Care environments.

Learn more about the LIFT-AD Trial, a Phase 2 Study of an investigational drug for the treatment of mild to moderate Alzheimer’s disease and about the Neuropsychiatric Research Center.

Lead image courtesy of Pexels/Marcelo Chagas

See omnystudio.com/listener for privacy information.